|
Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 Trials |
|
|
|
Titel: |
Ravulizumab in Atypical Hemolytic Uremic Syndrome: An Analysis of 2-Year Efficacy and Safety Outcomes in 2 Phase 3 Trials |
Auteur: |
Dixon, Bradley P. Kavanagh, David Aris, Alvaro Domingo Madrid Adams, Brigitte Kang, Hee Gyung Wang, Edward Garlo, Katherine Ogawa, Masayo Amancha, Praveen Chakravarty, Sourish Heyne, Nils Kim, Seong Heon Cataland, Spero Yoon, Sung-Soo Miyakawa, Yoshitaka Luque, Yosu Muff-Luett, Melissa Tanaka, Kazuki Greenbaum, Larry A. |
Verschenen in: |
Kidney medicine |
Paginering: |
Jaargang 6 () nr. 8 pagina's p. |
Jaar: |
2024 |
Inhoud: |
|
Uitgever: |
The Authors |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|